Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Novavax
NVAX
$1.27B
| $13.6M | ﹤0.01% |
1,323,851
+362,393
| +38% | +$6.4M |
|
2277
Bentley Systems
BSY
$10.7B
| $13.6M | ﹤0.01% |
368,027
+44,415
| +14% | +$1.61M |
|
2278
Hawaiian Electric Industries
HE
$2.16B
| $13.6M | ﹤0.01% |
325,011
-25,420
| -7% | -$981K |
|
2279
Fox Class B
FOX
$23.2B
| $13.6M | ﹤0.01% |
476,811
-410,706
| -46% | -$11.8M |
|
2280
PUT
Philip Morris
PM
$293B
| $13.5M | ﹤0.01% |
133,700
+11,800
| +10% | +$1.11M |
|
2281
Regenxbio
RGNX
$745M
| $13.5M | ﹤0.01% |
596,468
-34,695
| -5% | -$784K |
|
2282
Amalgamated Financial
AMAL
$1.5B
| $13.5M | ﹤0.01% |
586,980
-43,167
| -7% | -$1.05M |
|
2283
Vanguard Russell 1000 Growth ETF
VONG
$44.7B
| $13.5M | ﹤0.01% |
245,185
-234,984
| -49% | -$13.3M |
|
2284
Vanguard Morningstar Large-Cap ETF
VV
$54B
| $13.5M | ﹤0.01% |
77,558
+39,159
| +102% | +$6.87M |
|
2285
CALL
Palo Alto Networks
PANW
$293B
| $13.5M | ﹤0.01% |
193,600
+58,000
| +43% | +$4.66M |
|
2286
PUT
Devon Energy
DVN
$47.4B
| $13.5M | ﹤0.01% |
219,500
+33,500
| +18% | +$2.28M |
|
2287
America Movil
AMX
$71.8B
| $13.5M | ﹤0.01% |
740,329
-339,379
| -31% | -$6.27M |
|
2288
Fastly Inc
FSLY
$3.61B
| $13.5M | ﹤0.01% |
1,644,410
+728,580
| +80% | +$6.38M |
|
2289
Brink's
BCO
$4.65B
| $13.5M | ﹤0.01% |
250,677
+40,986
| +20% | +$2.37M |
|
2290
Sally Beauty Holdings
SBH
$1.51B
| $13.4M | ﹤0.01% |
1,071,388
-2,634
| -0.2% | -$32.3K |
|
2291
RXO
RXO
$3.34B
| $13.4M | ﹤0.01% |
+777,863
| New | +$13.8M |
|
2292
First Hawaiian
FHB
$3.35B
| $13.3M | ﹤0.01% |
510,527
-80,437
| -14% | -$2.06M |
|
|
MRTX
2293
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.3M | ﹤0.01% |
292,698
+74,440
| +34% | +$4.82M |
|
2294
Lumen
LUMN
$6.09B
| $13.3M | ﹤0.01% |
2,539,194
-3,080,950
| -55% | -$18.9M |
|
2295
Costamare
CMRE
$1.8B
| $13.2M | ﹤0.01% |
1,426,850
+123,557
| +9% | +$1.16M |
|
2296
Beyond Meat
BYND
$272M
| $13.2M | ﹤0.01% |
1,073,761
-399,685
| -27% | -$5.57M |
|
2297
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $13.2M | ﹤0.01% |
216,743
-5,188
| -2% | -$310K |
|
2298
Generac Holdings
GNRC
$12.5B
| $13.2M | ﹤0.01% |
130,934
+13,306
| +11% | +$1.51M |
|
2299
Fulton Financial
FULT
$4.67B
| $13.2M | ﹤0.01% |
782,581
-54,655
| -7% | -$958K |
|
2300
PUT
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $13.1M | ﹤0.01% |
+430,000
| New | +$13.4M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.